Sep 9, 2024, 14:40
New study suggests significant overdiagnosis of prostate cancer in Europe – IARC
IARC – International Agency for Research on Cancer shared the following on LinkedIn:
“A new study, published today in The BMJ, suggests significant overdiagnosis of prostate cancer in Europe due to highly variable patterns of opportunistic testing with a blood test that measures the amount of prostate-specific antigen (PSA).”
Authors: Salvatore Vaccarella, Mengmeng Li, Freddie Bray, Rune Kvale, Diego Serraino, Valentina Lorenzoni, Anssi Auvinen, Luigino Dal Maso
Source: IARC – International Agency for Research on Cancer/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 14, 2024, 17:42
Oct 14, 2024, 17:03
Oct 14, 2024, 16:54
Oct 14, 2024, 16:53
Oct 14, 2024, 16:51
Oct 14, 2024, 16:46